β-Glucuronidase inhibitory activity of bromophenol isolated from red alga Grateloupia lancifolia
2021
The Han Nguyen | Patrick Achiever Blamo Jr | Xiaoyong Liu | Thi Van Anh Tran | Sang Moo Kim
The human gastrointestinal (GI) tract plays an important role in disease and health. The overexpression of β-glucuronidase, an enzyme produced in the gastrointestinal tract, has been found to cause the retoxification of potentially damaging substances already detoxified by liver glucuronidation. Thus, β-glucuronidase has been implicated in a number of diseases including colon cancer, liver disease and Crohn's disease. This study investigated β-glucuronidase inhibitory activity of a bromophenol purified from the red alga Grateloupia lancifolia. Using an assay-guided fractionation technique, a bromophenol, bis(2, 3-dibromo-4, 5-dihydroxybenzyl) ether, a bromophenol, was isolated from the red alga G. lancifolia. Its structure was elucidated on the basis of extensive 1D- and 2D-NMR studies, high resolution EI-MS analysis and comparisons with literature data. Bis(2, 3-dibromo-4, 5-dihydroxybenzyl) ether showed potent β-glucuronidase inhibitory activity. The IC<sub>50</sub> and K<sub>I</sub> values of bromophenol against E. coli β-glucuronidase were 0.54 and 0.53 mM, respectively. This bromophenol inhibited β-glucuronidase competitively and was stable at pH 2 up to 40 min at 37 ℃.
显示更多 [+] 显示较少 [-]